Compounds > bicalutamide

bicalutamide and Lymph Node Metastasis

bicalutamide has been researched along with Lymph Node Metastasis in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's12 (66.67)29.6817
2010's6 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cruz-Conde de Boom, R; de Lara-Simón, IM; Flores-Terry, MÁ; García-Arpa, M1
Cheng, HH; Fu, ZC; Li, DS; Lin, GS; Luo, HC1
Daverede, L; Harnden, P; Jagdev, SP; Paul, A; Ralph, C; Trainor, S; Trigonis, I; Vasudev, NS; Weston, M1
Doreswamy, K; Karthikeyan, VS; Nagabhushana, M; Shankaranand, B1
Brogley, M; Chinnaiyan, A; Dhanasekaran, S; Hofer, MD; Kuefer, R; Lapensee, EW; O'Mahony, OA; Pienta, KJ; Rehman, H; Robins, DM; Rubin, MA; Steinkamp, MP1
Coleman, CN; Gulley, J; Kamrava, M; Kaushal, A; Madan, RA; Tsang, KY1
Jaspers, HC; Mattijssen, V; Schoffelen, R; Slootweg, PJ; van der Graaf, WT; van Herpen, CM; Verbist, BM1
Chuu, CP; Fukuchi, J; Hiipakka, RA; Huo, C; Kokontis, JM; Liao, S; Lin, CY; Lin, HP; Su, LC1
Akaza, H; Arai, Y; Igawa, M; Kanetake, H; Kumon, H; Matsuda, T; Naito, S; Ohashi, Y; Soeda, A; Usami, M; Yamaguchi, A1
Carroll, K; Chodak, G; Delaere, KP; Gleason, D; Iversen, P; Johansson, JE; Klimberg, I; Lundmo, P; McLeod, DG; Montie, J; Morris, T; See, WA; Tammela, TL; Tyrrell, C; Wallace, DM; Wirth, MP1
Akakura, K; Akaza, H; Fukagai, T; Gillatt, D; Keane, T; Klotz, L; Morris, C; Payne, H1
Kirby, R1
de Crevoisier, R; Fizazi, K; Massard, C; Plantade, A1
Nemoto, K; Tomita, Y1
Ersoy, H; Gucuk, O; Han, U; Sagnak, L; Topaloglu, H1
Akaza, H; Arai, Y; Deguchi, T; Fujisawa, M; Hayashi, M; Hirao, Y; Kanetake, H; Naito, S; Namiki, M; Ohashi, Y; Tachibana, M; Usami, M1
Aguayo, J; Cole, A; Martin, E; Mathew, A; Mendelblatt, D; Vesely, DL1
Rigatti, P; Scattoni, V1

Reviews

2 review(s) available for bicalutamide and Lymph Node Metastasis

ArticleYear
[Reevaluation of MAB therapy and progress of endocrine therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:5

    Topics: Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Goserelin; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Survival Rate; Tosyl Compounds

2005
[Locally advanced prostate cancer: definition, prognosis and treatment].
    Bulletin du cancer, 2007, Volume: 94, Issue:7 Suppl

    Topics: Androgen Antagonists; Anilides; Chemotherapy, Adjuvant; Disease Progression; Humans; Lymphatic Metastasis; Male; Neoplasm Staging; Nitriles; Pelvis; Prognosis; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiotherapy; Tosyl Compounds

2007

Trials

3 trial(s) available for bicalutamide and Lymph Node Metastasis

ArticleYear
Superior anti-tumor efficacy of bicalutamide 80 mg in combination with a luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist monotherapy as first-line treatment for advanced prostate cancer: interim results of a randomized study in Ja
    Japanese journal of clinical oncology, 2004, Volume: 34, Issue:1

    Topics: Aged; Anilides; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disease-Free Survival; Double-Blind Method; Goserelin; Humans; Japan; Leuprolide; Lymphatic Metastasis; Male; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Tosyl Compounds; Treatment Outcome

2004
Is the efficacy of hormonal therapy affected by lymph node status? data from the bicalutamide (Casodex) Early Prostate Cancer program.
    Urology, 2004, Volume: 63, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents; Disease Progression; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Regression Analysis; Tosyl Compounds

2004
Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: a multicenter, randomized, double-blind, comparative study.
    Journal of cancer research and clinical oncology, 2008, Volume: 134, Issue:12

    Topics: Aged; Androgen Antagonists; Anilides; Bone Neoplasms; Double-Blind Method; Gonadotropin-Releasing Hormone; Humans; Lymphatic Metastasis; Male; Neoplasm Staging; Nitriles; Prognosis; Prostatic Neoplasms; Quality of Life; Survival Rate; Tosyl Compounds; Treatment Outcome

2008

Other Studies

13 other study(ies) available for bicalutamide and Lymph Node Metastasis

ArticleYear
Cutaneous Metastases From Adenocarcinoma of the Prostate.
    Actas dermo-sifiliograficas, 2018, Volume: 109, Issue:4

    Topics: Adenocarcinoma; Aged, 80 and over; Anilides; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Fatal Outcome; Goserelin; Humans; Lymphatic Metastasis; Male; Nitriles; Prostatic Neoplasms; Skin Neoplasms; Skin Ulcer; Tosyl Compounds; Transurethral Resection of Prostate

2018
Intensity-modulated radiotherapy combined with endocrine therapy for intermediate and advanced prostate cancer: long-term outcome of Chinese patients.
    Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:8

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cystitis; Follow-Up Studies; Goserelin; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nitriles; Proctitis; Prognosis; Prostatic Neoplasms; Radiation Injuries; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Survival Rate; Tosyl Compounds

2013
Metastatic castrate-resistant prostate cancer with a late, complete and durable response to docetaxel chemotherapy: a case report.
    Journal of medical case reports, 2014, Apr-09, Volume: 8

    Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Docetaxel; Goserelin; Humans; Lymphatic Metastasis; Male; Nitriles; Prostate; Prostatic Neoplasms; Taxoids; Tosyl Compounds; Treatment Failure; Treatment Outcome

2014
Prostatic adenocarcinoma presenting as isolated inguinal lymphadenopathy.
    BMJ case reports, 2015, Jul-07, Volume: 2015

    Topics: Adenocarcinoma; Aged; Anilides; Antineoplastic Agents; Humans; Lymphatic Diseases; Lymphatic Metastasis; Male; Nitriles; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Tomography, X-Ray Computed; Tosyl Compounds; Treatment Outcome

2015
Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapy.
    Cancer research, 2009, May-15, Volume: 69, Issue:10

    Topics: Amino Acid Substitution; Anilides; Antineoplastic Agents; Autopsy; Cycloheximide; DNA Primers; Flutamide; Humans; Lymphatic Metastasis; Male; Mutation; Nitriles; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Tosyl Compounds

2009
Long-term survival and PSA control with radiation and immunotherapy for node positive prostate cancer.
    Clinical & developmental immunology, 2009, Volume: 2009

    Topics: Adenocarcinoma; Anilides; Antineoplastic Agents, Hormonal; B7-1 Antigen; Cancer Vaccines; Goserelin; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Engineering; Radiography, Abdominal; Radiotherapy; T-Lymphocytes; Tosyl Compounds; Ultrasound, High-Intensity Focused, Transrectal; Vaccines, Synthetic

2009
Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment options.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jun-01, Volume: 29, Issue:16

    Topics: Anilides; Antineoplastic Agents; Bone Neoplasms; Brain Neoplasms; Carcinoma, Ductal; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nitriles; Receptors, Androgen; Salivary Ducts; Salivary Gland Neoplasms; Tosyl Compounds

2011
Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc.
    Cancer science, 2011, Volume: 102, Issue:11

    Topics: Adenocarcinoma; Androgen Antagonists; Anilides; Animals; Cell Cycle; Cell Division; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p27; Drug Implants; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Male; Metribolone; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Nitriles; Orchiectomy; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; Receptors, Androgen; S-Phase Kinase-Associated Proteins; Testosterone; Tosyl Compounds; Xenograft Model Antitumor Assays

2011
Case study: management of lymph node-positive disease detected at radical prostatectomy.
    Prostate cancer and prostatic diseases, 2005, Volume: 8, Issue:3

    Topics: Adenocarcinoma; Aged; Anilides; Biopsy; Disease Progression; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Metastasis; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Prunus; Quality of Life; Tosyl Compounds; Vitamin B Complex

2005
Neuroendocrine differentiation of localized prostate cancer during endocrine therapy.
    Scandinavian journal of urology and nephrology, 2007, Volume: 41, Issue:6

    Topics: Adenocarcinoma; Aged; Anilides; Antineoplastic Agents, Hormonal; Cell Differentiation; Goserelin; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds

2007
Skip metastase on the left neck lymph nodes of the prostatic adenocarcinoma with neuroendocrine differentiation and accompanying thyroid micropapillary carcinoma.
    Pathology oncology research : POR, 2008, Volume: 14, Issue:4

    Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Androgen Antagonists; Anilides; Cell Differentiation; Humans; Incidental Findings; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Multiple Primary; Nitriles; Orchiectomy; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Thyroid Neoplasms; Thyroidectomy; Tosyl Compounds; Whole Body Imaging

2008
Metastatic prostate cancer (with prostate-specific antigen of 9996) presenting as obstructive jaundice.
    The American journal of the medical sciences, 2000, Volume: 319, Issue:2

    Topics: Aged; Alkaline Phosphatase; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Bone Neoplasms; Cholestasis; Humans; Leuprolide; Lymphatic Metastasis; Male; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds; Treatment Outcome

2000
[Efficacy of bicalutamide in adjuvant treatment of prostatic carcinoma after primary therapy with curative aim. The viewpoint of the surgeon].
    Recenti progressi in medicina, 2002, Volume: 93, Issue:3

    Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Tosyl Compounds

2002